Diabetes in Pregnancy
Aus der Reihe
Oxford Diabetes Library
-
- Einzelkauf Download ausgewählt
-
Sprache:Englisch
28,80 €
inkl. gesetzl. MwSt.Beschreibung
Produktdetails
Format
Kopierschutz
Ja
Family Sharing
Nein
Text-to-Speech
Nein
Erscheinungsdatum
05.07.2012
Herausgeber
Robert LindsayVerlag
Oxford University PressSeitenzahl
112 (Printausgabe)
Dateigröße
802 KB
Sprache
Englisch
EAN
9780191502316
Diabetes is one of the most common medical conditions to complicate pregnancy. Gestational diabetes (diabetes with onset or first recognition in pregnancy) may complicate between 2 and 20% of pregnancies depending on the criteria used. Type 1 or Type 2 diabetes complicates over 1 in 300 pregnancies, and both have major implications for mother and child.
The management of diabetes during pregnancy has seen a number of major innovations in recent years. Insulin analogues have been introduced, and technical innovations include improvements in insulin pumps and the development of continuous glucose monitoring devices. The evidence base for the management of gestational diabetes has improved markedly, and the investigations based around the Hyperglycaemia and Adverse Pregnancy Outcomes (HAPO) study promise to revolutionise our understanding of the risks of adverse outcomes in pregnancy. The Australian Carbohydrate Intolerance Study (ACHOIS) has demonstrated that identification and glycaemic management of gestational diabetes leads to reduction in birth weight, macrosomia and adverse pregnancy outcomes. Finally, recent randomised control trials have explored use of oral hypoglycaemics (metformin, glibenclamide) in pregnancy.
Part of the Oxford Diabetes Library series, 'Diabetes in Pregnancy' summarizes the key aspects of the medical management of diabetes during pregnancy with an emphasis on clinical management. The volume is designed for all members of the multidisciplinary team and will act as a practical introduction particularly for obstetricians and endocrinologists in training.
The management of diabetes during pregnancy has seen a number of major innovations in recent years. Insulin analogues have been introduced, and technical innovations include improvements in insulin pumps and the development of continuous glucose monitoring devices. The evidence base for the management of gestational diabetes has improved markedly, and the investigations based around the Hyperglycaemia and Adverse Pregnancy Outcomes (HAPO) study promise to revolutionise our understanding of the risks of adverse outcomes in pregnancy. The Australian Carbohydrate Intolerance Study (ACHOIS) has demonstrated that identification and glycaemic management of gestational diabetes leads to reduction in birth weight, macrosomia and adverse pregnancy outcomes. Finally, recent randomised control trials have explored use of oral hypoglycaemics (metformin, glibenclamide) in pregnancy.
Part of the Oxford Diabetes Library series, 'Diabetes in Pregnancy' summarizes the key aspects of the medical management of diabetes during pregnancy with an emphasis on clinical management. The volume is designed for all members of the multidisciplinary team and will act as a practical introduction particularly for obstetricians and endocrinologists in training.
Noch keine Bewertungen vorhanden
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.
Kurze Frage zu unserer Seite
Vielen Dank für Ihr Feedback
Wir nutzen Ihr Feedback, um unsere Produktseiten zu verbessern. Bitte haben Sie Verständnis, dass wir Ihnen keine Rückmeldung geben können. Falls Sie Kontakt mit uns aufnehmen möchten, können Sie sich aber gerne an unseren Kund*innenservice wenden.
zum KundenserviceWeitere Artikel finden Sie in
- eBooks >
- Fachbücher >
- Medizin